Results 231 to 240 of about 288,605 (343)

Nanostructure and Collagen‐Stimulating Activity of Cationic Pentapeptide Lipopeptides

open access: yesJournal of Peptide Science, Volume 32, Issue 8, August 2026.
The self‐assembly in aqueous solutions, cytocompatibility and collagen production of lipopeptide C16–KTTKS (C16: hexadecyl) and a variant with arginine substitution for lysine, C16–RTTRS, are compared. ABSTRACT The self‐assembly in aqueous solutions, cytocompatibility, and collagen production of lipopeptide C16–KTTKS and a variant with arginine ...
Lucas R. de Mello   +3 more
wiley   +1 more source

Characterization and Removal of Multispecies Biofilms Formed by L. monocytogenes, S. aureus, and E. coli

open access: yesJournal of Food Safety, Volume 46, Issue 4, August 2026.
The formation of mono‐, dual‐, and triple‐species biofilms by L. monocytogenes, S. aureus, and E. coli was characterized by cell growth, metabolic activity, staining, and microscopy. Their resistance to a commercial disinfectant (NaOCl) and natural agents such as vinegar and lactic acid was evaluated.
Viviana Švarcová   +6 more
wiley   +1 more source

Unravelling the Significance of Cystatin C and Bunina Bodies in Amyotrophic Lateral Sclerosis Pathogenesis

open access: yesNeuropathology and Applied Neurobiology, Volume 52, Issue 4, August 2026.
ABSTRACT Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a fatal neurodegenerative disease primarily affecting motor neurons. Two key protein inclusions found in lower motor neurons serve as neuropathological hallmarks of the disease in human tissue: the TDP43‐positive inclusion and the cystatin C‐positive Bunina body.
Sarah M. Granger   +5 more
wiley   +1 more source

QBP1 Peptide as a Potential Anti‐Amyloidogenic Therapy for Type 2 Diabetes: An In Vitro Study

open access: yesAdvanced Science, Volume 13, Issue 37, 3 July 2026.
The anti‐amyloidogenic peptide QBP1 effectively halts human islet amyloid polypeptide (hIAPP) aggregation, preventing the formation of toxic β‐structured intermediates. Through a combination of biophysical assays, molecular dynamics, and cell‐based studies, QBP1 is shown to preserve β‐cell viability and metabolic homeostasis, positioning it as a ...
María M. Tejero‐Ojeda   +8 more
wiley   +1 more source

Elimination of tau tangles and soluble aggregates with the small molecule ACI‐16664 prevents neurodegeneration in vivo

open access: yesAlzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION Pathological tau aggregates are key therapeutic targets in Alzheimer's disease (AD), but current approaches face limitations including poor intracellular penetration, lack of selectivity for aggregated over physiological tau, or reliance on invasive administration.
Nicolas Preitner   +19 more
wiley   +1 more source

Acute viral encephalitis impacts dense‐core amyloid plaque pathology and dysregulates myeloid responses to amyloid plaques

open access: yesAlzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION Recent epidemiological datasets have associated viral encephalitis exposure (i.e., viral‐induced neuroinflammation) with increased risk of Alzheimer's disease (AD) and dementia, highlighting the need to uncover how it may impact AD neuropathology.
Dominic Ibarra Javonillo   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy